Skip to Content
You are currently on the new version of our website. Access the old version .
  • 3.3
    Impact Factor
  • 4.3
    CiteScore
  • 22 days
    Submission to First Decision
  • 4 days
    Acceptance to Publication

Neurology International

Neurology International is an international, peer-reviewed, open access journal which provides an advanced forum for studies related to all aspects of neurology and neuroscience, published monthly online by MDPI (since Volume 12, Issue 3 - 2020). The Panhellenic Federation of Alzheimer's Disease and Related Disorders (PFADRD) is affiliated with Neurology International and its members receive discounts on the article processing charges.

Get Alerted

Add your email address to receive forthcoming issues of this journal.

All Articles (1,059)

  • Review
  • Open Access

Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive neurostimulation therapy with established evidence in the treatment of depression. Despite its clinical use, the mechanism(s) underlying the therapeutic effects of rTMS for depression is not yet understood. The excitation–inhibition (E–I) imbalance framework suggests that disruptions in the balance between excitatory and inhibitory neural activity contribute to the pathophysiology of several neuropsychiatric disorders, and it proposes a candidate explanation for how rTMS exerts its antidepressant effect. Understanding the mechanism of action of rTMS enables the refinement of rTMS protocols for better efficacy and positions rTMS as an intervention in disorders where excitation/inhibition imbalance contributes to the underlying etiology. In this narrative review, we review evidence for E–I imbalance in depression, describe the effects of rTMS on excitatory and inhibitory systems at the molecular, cellular, and cortical levels, and integrate these findings to evaluate whether the restoration of E–I balance is a plausible mechanism of action. While findings are mixed and adequately powered, longitudinal, controlled studies are needed, the available evidence is broadly consistent with an E–I model of rTMS in depression. This review and our proposed model can serve as a foundation for future mechanistic work in this field.

Neurol. Int.

15 November 2026

This conceptual diagram depicts the signal-to-noise ratio, with overlapping waveforms depicting noise and wavelength thickness depicting signal strength. (A) The noise ratio is elevated relative to signal. Increased excitation or decreased inhibition creates a hyperexcitable circuit with reduced efficacy of signal transmission. (B) The signal-to-noise ratio is balanced. Excitatory and inhibitory activity are balanced, and signal transmission is optimal. (C) The ratio of signal is low relative to noise. Decreased excitation or increased inhibition causes decreased efficacy of signal transmission. Created with BioRender.com.
  • Article
  • Open Access

Background/Objectives: Parkinson’s disease (PD) is a rapidly growing cause of neurological disability, yet diagnosis is often delayed in settings with limited access to movement-disorder specialists, including Kazakhstan and other Central Asian countries. This study aimed to develop a brief, self-administered, two-stage machine-learning-derived questionnaire based on binary symptom responses to identify individuals with possible clinically manifest PD who may benefit from specialist neurological assessment, and to evaluate its performance. Methods: From outpatient records of 402 patients with confirmed PD, a preliminary 100-item yes/no questionnaire was compiled. In a development cohort of 389 participants aged 60 to 90 years (146 with PD, 243 controls) recruited in Almaty, Kazakhstan, we used ElasticNet logistic regression, random forest, and gradient boosting to select features, reducing the instrument to 35 items (15 in Stage 1, 20 in Stage 2). We assessed performance on a held-out test set (n = 78) and in an interim prospective external-validation cohort (n = 290) recruited independently, with neurologists blinded to questionnaire results. Results: On the held-out test set, sensitivity was 86.2%, specificity 89.8%, accuracy 88.5%, and Stage 1 AUC 0.9557. In the interim external validation, sensitivity was 95.1%, specificity 94.4%, accuracy 94.5%, NPV 99.2%, and Stage 1 AUC 0.9962; only 12.1% of participants required Stage 2. Conclusions: The two-stage questionnaire showed strong case-finding ability in identifying individuals who warrant neurological evaluation. Findings are interim; completion of external validation, larger geographically diverse cohorts, and comparison against existing instruments are needed before wider implementation.

Neurol. Int.

9 November 2026

  • Editorial
  • Open Access

Successful recanalisation after acute ischaemic stroke does not guarantee neurological recovery. The Time, Tissue, and Systems (TTS) framework conceptualises outcomes as interactions among elapsed time, tissue vulnerability (including collateral status and microvascular integrity), and healthcare system performance. Recent evidence, including the LATE-MT trial, supports imaging-selected thrombectomy beyond 24 h, yet approximately half of patients experience so-called futile recanalisation. This Special Issue addresses the optimisation of reperfusion, tissue-level protection, and sustained recovery, with a special focus on distinguishing angiographic from tissue-level reperfusion, aligning neuroprotection with biological phenotypes, incorporating cognition and participation as clinical endpoints, and strengthening equitable systems of care. This framework provides an organising perspective for translating these advances into improved patient-centred outcomes.

Neurol. Int.

9 November 2026

  • Review
  • Open Access

Huntington Disease: Integrated Care Narratives

  • Daniele Orsucci,
  • Lucia Picchi and
  • Martina Giuntini
  • + 2 authors

Huntington disease (HD) is a complex neurogenetic disorder requiring coordinated, multidisciplinary management across disease stages. This narrative review summarizes the clinical features, genetic counselling, symptomatic pharmacological treatments, rehabilitation, swallowing and nutritional management, psychological care, and social support needs of individuals with HD. Particular attention is given to locally coordinated healthcare services and the role of the neurologist in facilitating multidisciplinary care. The literature-based discussion is complemented by a descriptive summary of 15 individuals evaluated in our local neurological services during the preceding year. These individuals showed considerable heterogeneity in clinical manifestations, functional disability, and care needs. Six of 15 individuals (40%) had at least one documented refusal or postponement involving heterogeneous recommended interventions. This observation was descriptive and was not intended as a standardized measure of adherence or service uptake. Integrated care requires regular reassessment, individualized treatment planning, effective communication among healthcare professionals, and sustained support for patients and families. Although the organization of care varies across healthcare systems, accessible local expertise and collaboration with specialist referral centres may help reduce fragmentation and promote continuity of care throughout the disease course.

Neurol. Int.

6 November 2026

Highly Accessed Articles

News & Conferences

Latest Issues

Open for Submission

Journal Sections

XFacebookLinkedIn
Neurol. Int. - ISSN 2035-8377